Daniel J. O'Connor - Feb 20, 2025 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Feb 20, 2025
Transactions value $
$0
Form type
3
Date filed
2/24/2025, 04:54 PM
Previous filing
Mar 7, 2024

No securities are beneficially owned.